Bpifrance has increased its investment in Exosens to 7.2%, reinforcing its role as a lead shareholder and signaling confidence in the company's strategic direction and growth potential within critical sectors.
Target Information
Founded in 1937, Exosens is a global leader in innovation, development, manufacturing, and sales of cutting-edge technologies in amplification, detection, and imaging. The company addresses complex challenges in demanding environments across sectors such as defense, life sciences, nuclear energy, and industrial control.
Since its IPO in June 2024, Exosens has demonstrated its ability to execute its roadmap and meet its operational and financial objectives. The company's stock performance reflects the market's confidence in its business prospects and the strategic direction set by its management team.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The defense industry in France is one of the most robust sectors, driven by advanced technological developments and the increasing emphasis on national security. France is recogni
Similar Deals
Hivest Capital → Safran’s Cargo and Catering activities
2023
Hivest Capital Partners → Cabin & Cargo Equipment Group
2023
Bpifrance
invested in
Exosens
in 2025
in a Corporate VC deal